Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
2011

Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy

publication Evidence: moderate

Author Information

Author(s): Sari Youssef

Primary Institution: University of Toledo

Hypothesis

The study explores the role of mutant huntingtin protein in neurodegeneration and the potential of neurotrophic factors in treating Huntington's disease.

Conclusion

Understanding the molecular mechanisms of mutant huntingtin protein may lead to therapeutic strategies that promote neuroprotection and restore neuronal function in Huntington's disease.

Supporting Evidence

  • Mutant huntingtin protein disrupts calcium homeostasis and transcriptional regulation.
  • Neurotrophic factors like BDNF and GDNF have shown potential in protecting neurons in Huntington's disease models.
  • Deficits in neurotrophic factors are linked to the progression of neurodegeneration in Huntington's disease.

Takeaway

Huntington's disease is caused by a faulty protein that damages brain cells, but scientists are looking at special proteins called neurotrophic factors that might help protect those cells.

Methodology

The review discusses various studies on the effects of mutant huntingtin protein and neurotrophic factors in Huntington's disease models.

Limitations

The review is based on existing studies and may not include all recent findings or clinical trials.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication